that is necessary to reestablish functional contractile activity after short-term global ischemia in heart is not known. To determine the relationship between DO 2 and recovery of contractile and metabolic functions, we used tissue NADH fluorometric changes to characterize adequacy of reperfusion flow. Isolated perfused rat hearts were subjected to global ischemia and were reperfused at variable flow rates that ranged from 1 to 100% of baseline flow. Myocardial function and tissue NADH changes were continuously measured. NADH fluorescence rapidly increased and plateaued during ischemia. A strong inverse logarithmic correlation between NADH fluorescence and reperfusion DO 2 was demonstrated (r ϭ Ϫ0.952). Left ventricular function (rate-pressure product) was inversely related to NADH fluorescence at reperfusion flows from 25 to 100% of baseline (r ϭ Ϫ0.922) but not at lower reperfusion flow levels. An apparent reperfusion threshold of 25% of baseline DO 2 was necessary to resume contractile function. At very low reperfusion flows (1% of baseline), another threshold flow was identified at which NADH levels increased beyond that observed during global ischemia (3.4 Ϯ 3.0%, means Ϯ SE, n ϭ 9), which suggests further reduction of the cellular redox state. This NADH increase at 1% of baseline reperfusion flow was blocked by removing glucose from the perfusate. NADH fluorescence is a sensitive indicator of myocardial cellular oxygen utilization over a wide range of reperfusion DO 2 values. Although oxygen is utilized at very low flow rates, as indicated by changes in NADH, a critical threshold of ϳ25% of baseline Ḋ O2 is necessary to restore contractile function after short-term global ischemia. ischemia; oxygen delivery; cardiac function; glucose AFTER THE GLOBAL ISCHEMIA of cardiac arrest, cardiopulmonary resuscitation (CPR) techniques provide marginal reperfusion of the heart. This period of low-flow reperfusion is of critical importance in patient survival but remains poorly understood. Questions surrounding the minimal levels of perfusion or oxygen delivery (DO 2 ) that are needed to facilitate the return of contractile function are unknown. Furthermore, theoretical concerns exist regarding the potentially deleterious effects of low-flow substrate (glucose) delivery without adequate oxygen for aerobic metabolism (25). To better characterize low-flow reperfusion, we have systematically altered Ḋ O 2 in our ischemic heart model and observed the responses of both contractile function and cellular redox state using an NADH autofluorescence technique.
AFTER THE GLOBAL ISCHEMIA of cardiac arrest, cardiopulmonary resuscitation (CPR) techniques provide marginal reperfusion of the heart. This period of low-flow reperfusion is of critical importance in patient survival but remains poorly understood. Questions surrounding the minimal levels of perfusion or oxygen delivery (DO 2 ) that are needed to facilitate the return of contractile function are unknown. Furthermore, theoretical concerns exist regarding the potentially deleterious effects of low-flow substrate (glucose) delivery without adequate oxygen for aerobic metabolism (25) . To better characterize low-flow reperfusion, we have systematically altered Ḋ O 2 in our ischemic heart model and observed the responses of both contractile function and cellular redox state using an NADH autofluorescence technique.
NADH has been used to characterize mitochondrial energy states in isolated hearts and myocardial tissue (6, 8, 24, 28) . Hypoxia and ischemia lead to blocking of the electron transport chain and accumulation of NADH due to inadequate Ḋ O 2 for continued oxidative phosphorylation (10) . Previous studies in isolated and perfused beating hearts describe accumulation of NADH during ischemia and report resolution on reperfusion (33) . However, NADH changes during incremental reperfusion that represents various states of Ḋ O 2 have not been studied. This is a critical issue after both in vivo regional and global ischemia due to a variable reperfusion flow to the ischemic myocardium. In previous studies, we noted the importance of the level of reperfusion flow on postischemic left ventricular (LV) function and myocardial bioenergetic recovery (14) . Previous animal studies of conventional CPR demonstrated maximal blood flow rates achieved that ranged from 10 to 30% of prearrest levels (7, 15, 19, 25, 30) . CPR-generated reperfusion after cardiac arrest represents a small fraction of normal physiological coronary artery flow (26, 27) . This in part accounts for the very low resuscitation rates after cardiac arrest (3, 16) . In the absence of good tissue or cellular markers, it is difficult to assess the adequacy of myocardium reperfusion. Characterizing the efficacy of very low-flow reperfusion after global ischemia remains an important question in resuscitation medicine.
In this study, we utilized tissue NADH levels as a real-time indicator of the postischemic return of mitochondrial function during variable levels of reperfusion flow (DO 2 ). NADH levels were noted to be a sensitive indicator of cellular DO 2 to the ischemic myocardium, and at higher reperfusion flows, NADH levels were inversely correlated with postischemic LV function. Our results help characterize postischemic reperfusion by demonstrating that any low-flow reperfusion (Ͼ1% of baseline) can improve the cellular NADH (redox state) toward an apparent critical threshold that is required for return of contractile function.
METHODS
Langendorff heart preparation. Male Sprague-Dawley rats (350-450 g body wt) supplied by Harlan (Indianapolis, IN) were used in accordance with guidelines of the National Institutes of Health (Guide for the Care and Use of Laboratory Animals, NIH Publication No. 85-23, Revised 1996) and the approval of the Ohio State University Laboratory Animal Resources Committee. Rats were anesthetized with pentobarbital sodium (50-65 mg/kg ip). The right superficial jugular vein was isolated, and 1,000 U/kg heparin was administered. The trachea was cannulated with a 16-gauge AngioCath attached to a rodent ventilator (Harvard Apparatus; South Natick, MA) set to provide adequate ventilation with room air. A midsternal thoracotomy was performed to expose the heart, and the aorta was cannulated. After cannulation, the heart was immediately perfused in situ with 95% O 2-5% CO2-bubbled Krebs-Henseleit bicarbonate buffer (in mM: 1.25 CaCl 2, 5.5 glucose, and 0.2 octanoic acid) at a constant pressure of 85 mmHg. The heart was quickly excised from the chest and transferred to the Langendorff apparatus with continued warmed (37°C) Krebs-Henseleit buffer perfusion at 85 mmHg. A saline-filled latex balloon attached to a pressure transducer was inserted into the left ventricle for measurement of LV function and heart rate. The heart was positioned in a glass temperature-controlled (37.4°C) chamber. Coronary flow rates were continuously measured and monitored by an electronic flow meter (T206, Transonic Systems; Ithaca, NY).
LV function measurements. The LV balloon volume was inflated at the beginning of the experiment to yield a LV end-diastolic pressure of 5 mmHg. The balloon volume remained constant during the experiment so that changes in the LV end-diastolic pressure were due to changes in myocardial compliance. LV pressure was continuously sampled at a frequency response of 45 Hz and was digitally processed by a heart-performance analyzer (Digi-Med, Micro-Med; Louisville, KY). The following measures of LV function were derived by computer algorithm and stored in a spreadsheet: LV systolic pressure, LV end-diastolic pressure, heart rate, dP/dt max, duration of contraction, duration of relaxation time, ϪdP/dtmax, and , a measure of diastolic relaxation. Developed pressure (DP, systolic Ϫ diastolic pressure), and rate-pressure product (RPP, developed pressure ϫ heart rate) were calculated.
Metabolic and chemical analyses. Samples of Krebs-Henseleit coronary perfusate as well as coronary venous effluent were collected and analyzed at baseline and at scheduled intervals throughout the protocol. A gas analyzer (Synthesis 45, Instrumentation Laboratory; Lexington, MA) was used to measure PO2, PCO2, pH, Na ϩ , K ϩ , Cl Ϫ , Ca 2ϩ , and glucose. In this non-hemoglobin-perfused model, myocardial DO2 and utilization (V O2) were calculated as the coronary perfusate flow normalized per gram of dry heart weight [(perfusate PO2 Ϫ effluent PO2) ϫ 24 l O2/ml]. Hearts were lyophilized (LABCONCO; Kansas City, MO) for 24 h and weighed to determine dry heart weight.
Measurement of NADH. NADH is an intrinsic fluorophore and plays a primary role in glycolysis and energy transfer from the tricarboxylic acid cycle to the electron transport chain of mitochondria. During ischemia, when DO2 is compromised, the respiratory chain becomes inhibited as oxygen concentration is reduced. NADH fluoresces (440-470 nm) (1) when tissue is excited by ultraviolet light. The oxidized cofactor NAD ϩ does not fluoresce. This fluorometry technique can be used to ascertain relative NADH concentration and thus the mitochondrial redox state. Autofluorescence spectroscopy is an accepted method for measuring NADH in isolated hearts and myocardial tissue (6, 8, 24, 28) . The majority of NADH measured is believed to originate from the mitochondria (2, 9, 24) . Impaired DO2 (ischemia) leads to accumulation of NADH (10, 33) from impaired oxidative phosphorylation in mitochondria.
NADH fluorescence at the LV wall was measured within a box that excluded extraneous light. A 6-mm-diameter fiber-optic bundle that contained Ͼ400 excitation and emission fibers was carefully positioned adjacent to and directed toward the anterior LV wall. A securing screen was adjusted on the contralateral side of the heart to ensure appropriate contact of the fiber-optic cable to the LV anterior wall. Positioning of the heart was done to prevent inhibition of LV function as indicated by the heart-performance analyzer. The proximal end of the fiber-optic cable was connected to a ratiometric fluorometer (Radnoti Glass; Monrovia, CA). Fluorescence was excited using a 150-W xenon arc lamp filtered through one of four alternating excitation filters on a filter wheel. A single excitation filter with a specific designated ultraviolet range was used to excite NADH at 330 nm with a band width (BW) of 80 nm. To minimize any photobleaching effect, the tissue was exposed to light for 8.5 ms of every 40-ms turn of the filter wheel, and the lamp shutter was left open for only 7 s out of every 30 s.
Autofluorescence emission of NADH was received by the emission fibers of the fiber-optic bundle. A photomultiplier within the spectrophotometer measured emission intensity. Fluorescence emission at 470 nm with a BW of 10 was interpreted as a measure of NADH. NADH signals were signal-averaged over the sampling periods, digitalized, and recorded in arbitrary fluorescence units.
Perfusion protocol. Hearts were perfused at a constant pressure of 85 mmHg at baseline and allowed to equilibrate for 15 min. The baseline flow rate (in ml/min) was measured and programmed into an infusion pump (Masterflex model 755-90, Cole Palmer Instruments; Chicago, IL). The pump allowed digital calibration of flow rate either to maintain baseline flow rate or as a percentage of baseline flow during postischemic reperfusion later in the protocol. In accordance with this initial equilibration period, hearts underwent 5 min of global ischemia. Hearts were then reperfused for 5 min with varied flow rates that reflected percentages of the initial baseline flow. Postischemic reperfusion flow rates studied included 100 (baseline), 75, 50, 25, 12.5, 6.25, and 1% of baseline values (n ϭ 7 rats/group). Periodic perfusate and coronary effluent gases were collected and analyzed to determine DO 2 and V O2 during both baseline and reperfusion. Full baseline flow was resumed after the 5-min controlled reperfusion interval. Real-time autofluorescence of NADH was recorded continuously in arbitrary NADH units during the various perfusion protocols. NADH autofluorescence during reperfusion was compared with baseline autofluorescence levels, thereby allowing each heart to serve as its own control. Each heart studied was limited to Յ4 intervals of ischemia-reperfusion to minimize the effects of stacking ischemic insults.
Additional experiments were done to assess NADH autofluorescence during "very low-flow" reperfusion rates (1-10% baseline flow) after global ischemia. To assess the effects of substrate manipulation during periods of very low reperfusion flow (1% of baseline), hearts were perfused after a 5-min period of global ischemia with reperfusion flow rates limited to 1% of baseline both with and without glucose (5.5 mM). NADH autofluorescence (n ϭ 9 per group) was monitored throughout baseline flow, global ischemia, 1% of baseline reperfusion flow (both with and without glucose), and full-flow reperfusion.
Data analysis. NADH autofluorescence signals were digitized and recorded in arbitrary NADH units. The NADH signal is highly dependent on positioning of the fluorometer fiber-optic cable against the left ventricle. Owing to this variability, comparison of absolute levels of arbitrary NADH units between hearts was not done. Each heart was used as its own control, so that changes in NADH were normalized to baseline NADH during normal perfusion, variable percentages of baseline flow, and global ischemia. The percent NADH change based on these two fluorescence extremes (NADHplateau/ NADHbaseline) was used to compare the various reperfusion flow rates. LV function characteristics of RPP, DP, and dP/dtmax were expressed as a ratio of baseline function using each heart as its own control. All group values were expressed as means Ϯ SE. Analysis was done using ANOVA and Tukey's post hoc test (SYSTAT, version 10.2.01, Systat Software; Richmond, CA). P Ͻ 0.05 was considered statistically significant.
Differences between 1%-flow groups with and without glucose were analyzed. Each heart served as its own control with its percent NADH change measured both with and without glucose. The normality of the percent change for both groups as well as the actual differences for both groups were assessed using standard tests (Shapiro-Wilk and Andersen-Darling). We tested the following hypotheses: 1) the average percent change with glucose is zero; 2) the average percent change without glucose is zero; and 3) the percent change with glucose equals the percent change without glucose (i.e., the difference is zero).
Correlations of NADH to DO2 were analyzed using linear regression. Correlation of NADH with LV function was performed using two linear regressions in which the interface between the two regressions was determined by minimizing the sum of the squared deviations. For this relationship, linear, logarithmic linear, and power functions were attempted but were eliminated due to poor correlations with the experimental data.
RESULTS
NADH fluorescence and variable reperfusion/DO 2 . In the ischemic and reperfused heart, NADH changes were very rapid in response to alterations in DO 2 (Fig. 1) . NADH quickly rose and approached a plateau during global ischemia. Partial levels of recovery toward the NADH baseline were observed with varied levels of postischemic reperfusion (n ϭ 7 at each reperfusion flow rate). Additional recovery of NADH toward baseline was noted with reinstitution of full (baseline) flow after each low-flow reperfusion period. Significant changes in NADH levels were noted relative to the end of ischemia with reperfusion flows ranging from 12.5 to 75% of baseline levels tested (P Ͻ 0.01; see Fig. 1 ).
NADH exhibited a strong inverse relationship to reperfusion flow rate (Fig. 2) . In this non-hemoglobin-perfused model, oxygen content of the perfusate is fixed and determined by the PO 2 in the saturated solution. As a result, DO 2 is a linear function of the perfusate flow rate (DO 2 ϰ perfusate flow rate). Therefore, the NADH-response curve relative to reperfusion flow and DO 2 is the same. Changes in NADH fluorescence relative to reperfusion DO 2 are not linear and are best described by a logarithmic relationship (Fig. 2) . The greatest changes in NADH signal occurred during the lower extremes of DO 2 (Fig.  2) . A strong correlation (r ϭ 0.952) was noted between myocardial V O 2 and DO 2 over the full range of reperfusion flows, which indicates the DO 2 -dependent nature of the perfused heart model at all levels of reperfusion (Fig. 3) .
NADH fluorescence and LV function. Measures of LV function were inversely correlated with NADH fluorescence including DP (r ϭ Ϫ0.755) and dP/dt max (r ϭ Ϫ0.766). However, a better fit of LV function to NADH was found by using the LV functional parameter RPP and creating two intersecting linear regression lines (Fig. 4) . During reperfusion at the lower extremes of DO 2 (1-25% of baseline), the NADH signal clearly returned toward baseline, which suggests improved tissue oxygenation, cellular redox state, and mitochondrial function (see Fig. 3 ). Relative changes in the NADH signal were greatest over these reperfusion flow rates. Despite this clear evidence of a metabolic response to low perfusion flow rates, no functional ) are closely correlated (r ϭ 0.952; P Ͻ 0.001), which suggests the DO2 dependence of the heart at reduced reperfusion levels.
contractile recovery was observed during reperfusion with 1-25% of baseline DO 2 . Conversely, at reperfusion DO 2 levels Ͼ25% of baseline, there was return of contractile function in proportion to the level of DO 2 . Over this range of reperfusion DO 2 , NADH changes were much smaller (Fig. 4 ). An apparent threshold was identified (corresponding to a reperfusion DO 2 of Ͻ25% of baseline and an NADH level Ͼ1.1 ϫ baseline preischemia level) below which no recovery of LV contractile function was observed. Similar functional relationships were noted with DP and dP/dt max . With reperfusion at 100% of baseline, there was a rapid return of LV function and recovery of NADH to near-baseline levels after short-term ischemia.
To confirm the hypothesis that 25% of baseline flow provides adequate DO 2 to maintain contractile activity of the perfused heart, additional hearts were perfused at 25% of baseline flow without prior global ischemia. Contractile function measured as the RPP immediately dropped and remained constant over the 2-h perfusion period at a mean of 26% of baseline RPP. NADH immediately increased and remained constant during the 2-h period.
NADH fluorescence during very low-flow reperfusion. Additional experiments (n ϭ 6) utilizing "very low-flow" reperfusion rates of 1, 2, 6.25, and 10% of baseline flow were studied. An apparent threshold was noted at ϳ1% of baseline flow at which NADH increased during reperfusion. In contrast, reperfusion flows Ͼ1% of baseline universally demonstrated a decrease in NADH fluorescence. We hypothesized that this increase in NADH was due to sufficient substrate (glucose) delivery stimulating glycolysis and greater NADH generation but with insufficient oxygen to support oxidative phosphorylation.
To evaluate the significance of glucose at these very low reperfusion flow rates, additional experiments (n ϭ 9 per group) were done to compare standard perfusate (5 mM glucose) with and without glucose at a flow rate of 1% of baseline flow after global ischemia. Changes in NADH fluorescence were expressed as a percent change from the global ischemia plateau. Reperfusion at 1% of baseline flow with glucose resulted in an increase in NADH of 3.4 Ϯ 3.0% [⌬NADH/ (NADH ischemia Ϫ NADH baseline) ϫ 100%] above the global ischemic level compared with a decrease in NADH of Ϫ3.6 Ϯ 5.4% in the nonglucose group (Fig. 5) . The mean percent change for the 1% of baseline flow with glucose was 3.4% and was significantly different from zero (P ϭ 0.0177). However, the average percent change for the 1% of baseline flow without glucose group was not significantly different from zero (P ϭ 0.1289). The average percent difference between the two groups of 6.9% is significant (P ϭ 0.0102). There was no difference in reperfusion DO 2 (measured in l O 2 ⅐min Ϫ1 ⅐g of dry wt Ϫ1 ) between groups (8.32 Ϯ 2.88 with glucose vs. 9.36 Ϯ 2.82 without glucose; P ϭ 0.23).
DISCUSSION
In contrast with many ischemia-reperfusion studies where reperfusion constitutes restitution of full flow, extreme variation in reperfusion flow exists within the regionally reperfused in vivo heart and in particular during CPR conditions following the global ischemia of clinical cardiac arrest. We used NADH autofluorescence, a recognized indicator of redox state and mitochondrial metabolism (6, 8, 10, 24, 28) , as a marker of mitochondrial V O 2 and assessed a wide range of postischemic reperfusion flow rates. In this study, NADH fluorescence in the whole heart was noted to quickly rise to a steady state during short periods of global ischemia and to rapidly decrease to a lower steady state in proportion to the DO 2 . With the utilization Fig. 4 . Left ventricular (LV) function and NADH fluorescence during variable reperfusion. LV function, reported as rate-pressure product (RPP) percentage of baseline, declines with increasing NADH fluorescence. NADH fluorescence increases are greatest at lower reperfusion flow rates (P Ͻ 0.001; 25-1% of baseline flow). At these low levels of reperfusion flow, LV function is negligible (P ϭ 0.29). NADH appears to be a sensitive marker for ongoing cellular redox changes during very low-flow reperfusion. As NADH levels decrease with reperfusion, a threshold is observed that corresponds to a DO2 of ϳ25% of baseline, at which point rapid recovery of LV function is seen. In contrast with higher NADH levels in which no correlation with RPP is seen (r ϭ Ϫ0.43), there is a strong correlation of NADH levels with RPP at NADH levels Ͻ1.1 (r ϭ Ϫ0.922). Fig. 5 . NADH fluorescence during reperfusion at 1% of baseline with oxygenated perfusate both with and without glucose (5.5 mM). The mean percent increase of NADH at 1% of baseline flow with glucose is 3.40 Ϯ 3.0% and is significantly different from zero (P ϭ 0.0177). However, the average percent decline at 1% of baseline flow without glucose is not significantly different from zero (Ϫ3.59 Ϯ 5.4%; P ϭ 0.1289). Mean percent difference between the two groups of 6.99% is significant (P ϭ 0.0102).
of a variety of reperfusion flow levels that ranged from 1 to 100% of baseline flow, a strong inverse logarithmic relationship was noted between NADH concentration and DO 2 . Spanning the full range of reperfusion flows, relative NADH fluorescence increased as DO 2 decreased.
Relative changes in NADH were greatest during reperfusion flow rates delivering 1 to 25% of baseline DO 2 . Interestingly, during this same range of reperfusion DO 2 , despite large decreases in the NADH concentration, there was no recovery of contractile function. The large changes in NADH with low reperfusion flows do indicate mitochondrial V O 2 at DO 2 levels below the apparent threshold for return of contractile function. In our model, this critical level of reperfusion DO 2 for return of contractile function was ϳ25% of baseline DO 2 .
Under conditions of very low-flow reperfusion, we identified another apparent DO 2 threshold (1% of baseline DO 2 ) where reperfusion increased peak NADH fluorescence above that of global ischemia. This increase in NADH was blocked by removal of glucose from the perfusate. Under normal nonischemic perfusion conditions, fatty acids are the preferred energy source for the heart (4, 17, 18) . However, under ischemic conditions, glucose becomes a dominant source for energy production as the ischemic heart shifts to anaerobic metabolism, thereby increasing both glucose uptake and glycogenolysis (21) . The relative reliance on glucose as an energy source is directly related to the severity of the ischemic insult. As ischemia becomes severe, glucose extraction increases inversely with coronary flow (5, 31) . Below a certain flow threshold, ϳ1% of normal flow in this model, delivery of additional glucose under severely hypoxic conditions may allow for additional glycolysis, thereby resulting in further accumulation of NADH but insufficient oxygen for oxidation of NADH in the mitochondria. This increase in the cellular reduced redox state under very low-flow reperfusion states has not been described in vivo. Although these reperfusion levels are very small (ϳ1% of normal flow), it is likely that these flow levels do exist during the variable reperfusion of the regionally ischemic myocardium and may occur during CPR-generated perfusion.
Significance of NADH accumulation. In this study, NADH was used as an indicator of mitochondrial function and cellular redox state. In previous studies of skeletal muscle bioenergetics, NADH fluorescence using spectrophotometry was identified as an excellent indicator of cellular PO 2 levels. In experiments on skeletal muscle, the degree of NADH decrease (NADH oxidation) shifts with oxygen availability during muscle hypoxia. As cellular hypoxia caused decreases in muscle performance, NADH was increasingly reduced rather than oxidized with increasing workloads (22) .
Myocardial NADH accumulation may have important implications for reactive oxygen species (ROS) generation during ischemia and reperfusion. ROS are believed to be a primary mechanism for reperfusion injury and myocardial dysfunction after ischemia. During early reperfusion, with the reintroduction of oxygen, there is a burst of ROS production (34, 35) . Significant contribution of accumulated NADH as a mechanism for this ROS reperfusion burst has recently been suggested (23) . Increased NADH levels during ischemia can serve as a trigger to increase ROS production via NADH oxidase activity on both xanthine dehydrogenase and xanthine oxidase (11, 12, 29) . Some authors believe that increased concentrations of NADH will preferentially inhibit xanthine dehydrogenase and shift the influx of purine-generated electrons through xanthine oxidase with consequent increased ROS production (12, 23) . As a potential mechanism for increased ROS production, increased NADH may serve as an indirect measure of ROS generation at reperfusion.
This work highlights some important limitations of the perfused heart as a model for studying in vivo global myocardial ischemia and reperfusion. Oxygenated perfusate lacks the oxygen-carrying capacity of a blood-perfused system. Owing to the absence of hemoglobin, oxygen-delivery capabilities of the buffer solution roughly approximate 10% of that seen in normal oxygenated blood. Under normal perfusion conditions in the perfused heart, coronary vasculature autoregulatory properties allow sufficient flow to prevent ischemia. Evidence for adequate perfusion in this model under full-flow conditions includes the preservation of function, the lack of NADH increase, and the lack of increased lactate production or creatine kinase release over prolonged periods of time. However, unlike the normal blood-perfused heart in which significant reductions in coronary blood flow may be tolerated without evidence of ischemia (13, 20, 32) , small reductions in flow of Ͻ25% in the Langendorff model result in accumulation of NADH and reduction in function. The linear relationship of myocardial DO 2 to myocardial V O 2 at flow levels Յ75% of baseline flow indicate that there is very little oxygen reserve at baseline-flow levels in this model. Thus reductions of flow in the non-blood-perfused heart correspond to proportionally greater reductions of flow under in vivo conditions. Under in vivo conditions, hemoglobin interference is possibly the most important confounding factor in assessing NADH fluorescence. As this is a non-blood-perfused model, this major limitation was not a factor.
In summary, NADH is a sensitive and instantaneous indicator of myocyte V O 2 in the whole heart under conditions of reperfusion. Using this tool, we observed that low reperfusion levels of DO 2 result in oxidation of NADH, presumably in the mitochondria, at DO 2 levels that are insufficient to support recovery of contractile function. In the perfused heart, postischemic reperfusion DO 2 levels Ͼ1% of baseline decrease NADH (oxidation). However, after short-term global ischemia, a threshold reperfusion DO 2 level of 25% of baseline is needed before the return of measurable contractile activity can occur. At very low reperfusion levels of Յ1% of baseline in this model, a paradoxical increase in NADH (reduction) was observed, which suggests that substrate as well as oxygen may be important determinants of myocardial NADH levels at very low reperfusion flows.
